Akso Health Group
AHG
$1.57
-$0.02-1.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -6.40% | 23.42% | 75.54% | 172.51% | 512.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.40% | 23.42% | 75.54% | 172.51% | 512.07% |
| Cost of Revenue | -8.07% | 22.80% | 79.65% | 184.14% | 556.98% |
| Gross Profit | 95.95% | 2,738.46% | -46.20% | -133.33% | -330.28% |
| SG&A Expenses | 9.54% | -16.91% | -30.41% | -45.85% | -58.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.65% | 10.21% | 28.36% | 45.48% | 69.20% |
| Operating Income | -1.97% | 18.23% | 29.77% | 43.60% | 54.58% |
| Income Before Tax | 87.55% | -8.72% | -2,445.93% | -2,029.55% | -1,728.80% |
| Income Tax Expenses | 93.55% | -7.17% | -79,128.06% | -96,330.53% | -123,304.00% |
| Earnings from Continuing Operations | 86.18% | -9.05% | -1,962.03% | -1,627.98% | -1,385.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -90.97% | 15.26% | 2,139.02% | 1,165.29% | 750.87% |
| Net Income | 86.17% | -9.02% | -1,959.36% | -1,586.61% | -1,327.00% |
| EBIT | -1.97% | 18.23% | 29.77% | 43.60% | 54.58% |
| EBITDA | 8.15% | -34.57% | -179.19% | -517.72% | -- |
| EPS Basic | 90.81% | 19.25% | -184.49% | -52.92% | -4.59% |
| Normalized Basic EPS | 23.81% | 87.20% | 92.16% | 95.55% | 96.89% |
| EPS Diluted | 89.49% | 20.63% | -153.55% | -44.34% | -0.81% |
| Normalized Diluted EPS | 23.81% | 87.20% | 92.16% | 95.55% | 96.89% |
| Average Basic Shares Outstanding | 82.56% | 134.45% | 266.42% | 376.36% | 739.23% |
| Average Diluted Shares Outstanding | 82.56% | 134.45% | 266.42% | 376.36% | 739.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |